Beer powerhouse Anheuser-Busch InBev (NYSE:BUD) will be announcing earnings results tomorrow morning. Here's what you need to know.
Anheuser-Busch missed analysts' revenue expectations by 7.2% last quarter, reporting revenues of $14.47 billion, down 1.3% year on year. It was a weak quarter for the company, with a miss of analysts' revenue and EPS estimates.
Is Anheuser-Busch a buy or sell going into earnings? Find out by reading the original article on StockStory, it's free.
This quarter, analysts are expecting Anheuser-Busch's revenue to grow 1.1% year on year to $14.37 billion, slowing from the 7.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.65 per share.
Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 2 downward revisions over the last 30 days. Anheuser-Busch has missed Wall Street's revenue estimates five times over the last two years.
Looking at Anheuser-Busch's peers in the beverages and alcohol segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Constellation Brands (NYSE:STZ) delivered year-on-year revenue growth of 7.1%, beating analysts' expectations by 2%, and MGP Ingredients (NASDAQ:MGPI) reported a revenue decline of 15.1%, in line with consensus estimates. Constellation Brands traded down 1% following the results while MGP Ingredients was up 2.9%.
Read the full analysis of Constellation Brands's and MGP Ingredients's results on StockStory.
Investors in the beverages and alcohol segment have had steady hands going into earnings, with share prices flat over the last month. Anheuser-Busch's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $71.9 (compared to the current share price of $60.08).
